ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 123 filers reported holding ANI PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $4,882,000 | +13.4% | 93,000 | +1.1% | 0.08% | +11.1% |
Q2 2017 | $4,306,000 | -1.2% | 92,000 | +4.5% | 0.07% | -6.5% |
Q1 2017 | $4,357,000 | -21.3% | 88,000 | +0.6% | 0.08% | -22.2% |
Q4 2016 | $5,535,000 | -4.7% | 87,500 | 0.0% | 0.10% | -8.3% |
Q3 2016 | $5,806,000 | +19.6% | 87,500 | +0.6% | 0.11% | +14.9% |
Q2 2016 | $4,856,000 | +80.3% | 87,000 | +8.8% | 0.09% | +70.9% |
Q1 2016 | $2,693,000 | +73.0% | 80,000 | +131.9% | 0.06% | +71.9% |
Q4 2015 | $1,557,000 | -47.8% | 34,500 | -54.3% | 0.03% | -50.0% |
Q3 2015 | $2,983,000 | -51.6% | 75,500 | -23.9% | 0.06% | -44.8% |
Q2 2015 | $6,158,000 | -2.0% | 99,250 | -1.2% | 0.12% | -4.9% |
Q1 2015 | $6,286,000 | -40.1% | 100,500 | -46.0% | 0.12% | -41.6% |
Q4 2014 | $10,490,000 | +110.5% | 186,025 | +5.6% | 0.21% | +99.0% |
Q3 2014 | $4,984,000 | -6.4% | 176,225 | +14.0% | 0.10% | -3.7% |
Q2 2014 | $5,322,000 | +18.0% | 154,525 | +7.4% | 0.11% | +11.2% |
Q1 2014 | $4,509,000 | – | 143,825 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |